investiment.io
Conduit Pharmaceuticals Inc.
$0.07
0.01 (13.87%)
Conduit Pharmaceuticals Inc.
$0.07
0.01 (13.87%)
CDT Price Chart
| Basic | |
|---|---|
| Market Cap | $10.87M |
| Price | $0.07 |
| 52 Week Range | 0.079-7.83 |
| Beta | 2.12 |
| Margins | |
| Gross Profit Margin | 48.58% |
| Operating Profit Margin | -0.92% |
| Net Profit Margin | -0.99% |
| Valuation (TTM) | |
| P/E Ratio | -0.48 |
| Price to Sales Ratio | 0.01 |
| Price to Book Ratio | -0.71 |
| PEG Ratio | -0.00 |
Industry
Biotechnology
Sector
Healthcare
Full-Time Employees
7
IPO Date
2022-03-28T00:00:00.000Z
Description
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Phone
760 471 8536
Address
4995 Murphy Canyon Road, San Diego, CA, 92134, US
CIK
0001896212